全民医保下心衰患者收入水平与结局
低收入的合并症负担更高且较少接受GDMT,其院内死亡率5.07%高于中收入2.47%和高收入2.51%;相比高收入组,低收入组出院后心衰再入院(aHR 1.29,95%CI 1.27-1.31)、全因死亡(aHR 1.98,95%CI 1.95-2.02)及复合终点(aHR 1.54,95%CI 1.52-1.56)风险显著更高,但差异随时间有所减轻。
要点
- 低收入心衰患者合并症更多且GDMT使用率更低。
- 低收入组院内死亡率5.07%,高于中收入2.47%和高收入2.51%。
- 低收入组出院后死亡风险约为高收入组的2倍(aHR 1.98)。
核心结论
- 低收入心衰患者院内死亡及出院后事件风险较高收入组增加近两倍,部分源于GDMT使用率较低。
- 全民医保实施后,不同收入组间出院后心衰结局差异随时间有所减轻。
研究设计与样本
- 按收入分为低、中、高三组,比较GDMT使用率、院内死亡率及出院后心衰再入院和死亡率。
- 采用倾向性匹配和逆概率治疗加权进行敏感性分析。
主要发现
- 低收入组合并症负担更高且更少接受GDMT。
- 院内死亡率:低收入组5.07%,中收入组2.47%,高收入组2.51%。
- 相比高收入组,低收入组出院后心衰再入院aHR 1.29(95%CI 1.27-1.31),全因死亡aHR 1.98(95%CI 1.95-2.02),复合终点aHR 1.54(95%CI 1.52-1.56)。
- 倾向性匹配后,低收入 vs 高收入:死亡HR 2.08,心衰再入院HR 1.36;中收入 vs 高收入:死亡HR 1.23,再入院HR 1.12(均p<0.001)。
- 逆概率加权后,低收入 vs 高收入:死亡HR 2.19,再入院HR 1.16;中收入 vs 高收入:死亡HR 1.53,再入院HR 1.09(均p<0.001)。
临床怎么用
- 对低收入心衰住院患者应关注GDMT的规范使用,以改善预后。
- 低收入心衰患者出院后事件风险高,需加强随访和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to investigate the influence of income level on guideline-directed medical therapy (GDMT) prescription rates and prognosis of patients with heart failure (HF) following implementation of a nationwide health insurance programme. METHODS: A total of 633 098 hospitalised patients with HF from 1996 to 2013 were identified from Taiwan National Health Insurance Research Database. Participants were classified into low-income, median-income and high-income groups. GDMT utilisation, in-hospital mortality and postdischarge HF readmission, and mortality rates were compared. RESULTS: The low-income group had a higher comorbidity burden and was less likely to receive GDMT than the other two groups. The in-hospital mortality rate in the low-income group (5.07%) was higher than in the median-income (2.47%) and high-income (2.51%) groups. Compared with the high-income group, the low-income group had a significantly higher risk of postdischarge HF readmission (adjusted HR (aHR): 1.29, 95% CI 1.27 to 1.31), all-cause mortality (aHR: 1.98, 95% CI 1.95 to 2.02) and composite HF readmission/all-cause mortality (aHR: 1.54, 95% CI 1.52 to 1.56). These results were generally consistent among the population after propensity matching (low vs high: HR=2.08 for mortality and 1.36 for HF readmission; median vs high: HR=1.23 for mortality and 1.12 for HF readmission; all p<0.001) and after inverse probability of treatment weighting (low-income vs high-income group: HR: 2.19 for mortality and 1.16 for HF readmission; median-income vs high-income group: HR: 1.53 for mortality and 1.09 for HF readmission; all p<0.001). Lower utilisation of GDMT and poorer prognosis in lower-income hospitalised patients with HF appeared to mitigate over time. CONCLUSIONS: Low-income patients with HF had nearly a twofold increase in the risk of in-hospital mortality and postdischarge events compared with the high-income group, partly due to lower GDMT utilisation. The differences between postdischarge HF outcomes among various income groups appeared to mitigate over time following the implementation of nationwide universal health coverage.
引用
- Hung CL, Chao TF, Su CH, et al. Income level and outcomes in patients with heart failure with universal health coverage. Heart. 2020. PMID: 33082175. doi:10.1136/heartjnl-2020-316793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。